How Hacks to Choose Startup the Right Keto ACV Gummies for You  Diario AS source

Eli Lilly & Co. is stepping up its fight against a booming black market for retatrutide, an experimental drug that the company is counting on to expand its crucial weight-loss franchise. For almost two years, Lilly has been warning consumers not to take knockoff versions of the shot that are being sold online and at…

John Goodman está casi irreconocible en una nueva foto tras años de una drástica pérdida de peso  Fox News source

Starbucks is pulling back coverage for weight-loss drugs, a reversal that comes as employers’ spending on popular GLP-1 medicines soars. Starting in October, the Seattle-based coffee chain’s health plans will no longer cover GLP-1 medications prescribed for weight loss for benefits-eligible employees, though the drugs may still be covered for other conditions. Starbucks offers health…

Amazon Pharmacy is offering Medicare patients weight loss drugs for $50 a month  qz.com source

Weight-loss drugs are becoming a popular employee perk, with almost a third of workers saying they’d switch jobs to get GLP-1 coverage. Now, Bank of America is spending $250 million or more yearly on the drugs for its staffers—and CEO Brian Moynihan says the upsides are well-worth the eye-watering cost. “What we see is a…

source

Kate Beckinsale took to social media to address the criticism surrounding her recent weight loss. On August 8, the 53-year-old reposted several cruel comments she had received on her Instagram Stories before penning a heartfelt response. The messages came from social media users urging her to gain weight and accusing her of using weight-loss drugs.…

The Ideal You Weight Loss Center  WGRZ source

Is BRP the Next GLP-1 Alternative? How It Quiets Food Noise Without Nausea  Woman’s World source

The TOI Lifestyle Desk is a dynamic team of dedicated journalists who, with unwavering passion and commitment, sift through the pulse of the nation to curate a vibrant tapestry of lifestyle news for The Times of India readers. At the TOI Lifestyle Desk, we go beyond the obvious, delving into the extraordinary. Consider us your…

Eli Lilly (LLY -0.52%) is already the leader in the weight-loss market thanks to Zepbound, the best-selling medication in this space. However, the drugmaker has been making headlines with its next-gen anti-obesity medicine, retatrutide. Eli Lilly recently announced that it will request approval from the U.S. Food and Drug Administration for retatrutide in the first…